PRIORITIES OF IMPORT SUBSTITUTION IN SEZ: BIOPHARMACEUTICS

I. V. Andryushchenko and H. H. Valiullin

Business Strategies, 2015, issue 8

Abstract: The Russia's pharmaceutical market is one of the most oriented on imported products. In particular, dependence of domestic insulin market from foreign production is now higher than 90%. The Western sanctions against Russia create a serious threat of the relevant drugs shortage. These conditions give the priority to the development of domestic biopharmaceutic technologies especially in SEZ.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.strategybusiness.ru/jour/article/viewFile/178/168 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aci:journl:y:2015:id:178

DOI: 10.17747/2311-7184-2015-8-1

Access Statistics for this article

More articles in Business Strategies from Real Economy Publishing House
Bibliographic data for series maintained by Кузнецов Ð Ð»ÐµÐºÑ ÐµÐ¹ Риколаевич ().